Nitorum Capital buys $15,016,626 stake in VCA Inc (WOOF)

VCA Inc (WOOF) : Nitorum Capital scooped up 11,950 additional shares in VCA Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Nov 14, 2016. The investment management firm now holds a total of 235,186 shares of VCA Inc which is valued at $15,016,626.VCA Inc makes up approximately 6.01% of Nitorum Capital’s portfolio.

Other Hedge Funds, Including , Bogle Investment Management L P De sold out all of its stake in WOOF during the most recent quarter. The investment firm sold 17,075 shares of WOOF which is valued $1,090,239.Marshall Wace Llp reduced its stake in WOOF by selling 332,826 shares or 63.85% in the most recent quarter. The Hedge Fund company now holds 188,460 shares of WOOF which is valued at $11,486,637. VCA Inc makes up approx 0.08% of Marshall Wace Llp’s portfolio.Acrospire Investment Management reduced its stake in WOOF by selling 300 shares or 23.08% in the most recent quarter. The Hedge Fund company now holds 1,000 shares of WOOF which is valued at $60,950. VCA Inc makes up approx 0.04% of Acrospire Investment Management’s portfolio.Advisors Asset Management reduced its stake in WOOF by selling 100 shares or 4.76% in the most recent quarter. The Hedge Fund company now holds 2,000 shares of WOOF which is valued at $121,140.

VCA Inc closed down -0.55 points or -0.84% at $64.84 with 6,42,077 shares getting traded on Monday. Post opening the session at $65.59, the shares hit an intraday low of $64.56 and an intraday high of $66.26 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, VCA Inc reported $0.79 EPS for the quarter, missing the analyst consensus estimate by $ -0.02 based on the information available during the earnings call on Oct 26, 2016. Analyst had a consensus of $0.81. The company had revenue of $656.90 million for the quarter, compared to analysts expectations of $668.39 million. The company’s revenue was up 19.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.68 EPS.

Many Wall Street Analysts have commented on VCA Inc. The Benchmark Company Initiated VCA Inc on Oct 24, 2016 to “Buy”, Price Target of the shares are set at $90.VCA Inc was Resumed by BofA/Merrill to “Buy” on Sep 29, 2016.

VCA Inc. is a national animal healthcare company operating in the United States and Canada. The Company operates in two segments: animal hospital and laboratory. The Company provides veterinary services and diagnostic testing to support veterinary care and also sells diagnostic imaging equipment and other medical technology products and related services to the veterinary market. The Company provides communication marketing solutions and other services to the veterinary community. The Company’s animal hospital offer general medical and surgical services pharmaceutical products and performs pet wellness programs. The Company’s communication and marketing solutions business provides services to veterinary practices pharmaceutical manufacturers and the pet owning community. The Company’s network of veterinary diagnostic laboratories provides sophisticated testing and consulting services.

Leave a Reply

VCA Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on VCA Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.